Skip to content

Inspire Medical Systems INSP Additional Paid-In Capital

Additional Paid-In Capital at other companies

ResMed logo
ResMedRMD
$2.13B+7.2%
LivaNova logo
LivaNovaLIVN
$2.25B+1.4%
Globus Medical logo
Globus MedicalGMED
$3.21B+5.0%
ITG
Integer HoldingsITGR
$755.87M+0.2%
Medtronic logo
MedtronicMDT
$20.93B+0.4%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's additional paid-in capital?
Inspire Medical Systems (INSP) reported additional paid-in capital of $950.45M in Q1 2026.
How has Inspire Medical Systems's additional paid-in capital changed year-over-year?
Inspire Medical Systems's additional paid-in capital increased by 2.8% year-over-year, from $924.41M to $950.45M.
What is the long-term trend for Inspire Medical Systems's additional paid-in capital?
Over 5 years (2020 to 2025), Inspire Medical Systems's additional paid-in capital has grown at a 14.7% compound annual growth rate (CAGR), from $467.04M to $927.16M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.